MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2018 International Congress

    Effects of PGE inhibition on Striatal Neuroinflammation in 6-OHDA lesion

    T. Adu, M. Mabandla (Durban, South Africa)

    Objective: In this study, we investigated the role of prostaglandin E2 inhibition, pro-inflammatory cytokine concentration and microglial activation in a Parkinsonian rat Background: Neuro-inflammation plays…
  • 2018 International Congress

    Educating Movement Disorders through a web based counselling service in Mauritius

    M. Busgopaul (Port Louis, Mauritius)

    Objective: The provision of solutions and relevant information to the general public and mostly to young people is the way forward to help the elderly…
  • 2018 International Congress

    Familial SCA2-parkinsonism presented as intractable oromandibular dystonia

    K. Woo, B. Jeon, J. Lee (Seoul, Republic of Korea)

    Objective: We report a patient of spinocerebellar ataxia type 2(SCA2)-parkinsonism family who developed oromandibular dystonia as the chief presentation. Background: We previously described a Korean…
  • 2018 International Congress

    Myoclonus in the pediatric age group: A retrospective analysis of clinical and electrophysiological characteristics of patients referred to an electrophysiology laboratory

    A. Gunduz, H. Yılmaz, V. Demirbilek, C. Yalçınkaya, N. Yeni, S. Saltık, M. E. Kızıltan (Istanbul, Turkey)

    Objective: We aimed to investigate clinical and electrophysiological features myoclonus in the pediatric age group. Background: Myoclonus is a movement disorder characterized by sudden, brief…
  • 2018 International Congress

    Broad White Matter Impairment in Multiple System Atrophy: A case for Oligodendrocyte Dysfunction

    N. del Campo, O. Phillips, F. Ory-Magne, M. Galitzky, C. Brefel-Coubron, C. Thalamas, K. Narr, S. Joshi, M. Singh, P. Péran, A. Pavy-LeTraon, O. Rascol (Toulouse, France)

    Objective: The main objective of this study was to investigate if there are widespread white matter abnormalities in multiple system atrophy (MSA). Background: MSA differs…
  • 2018 International Congress

    Insular atrophy as a marker of depression in Multiple System Atrophy: A voxel-based morphometry study

    N. del Campo, N. Wolpe, O. Phillips, C. Arbus, F. Ory-Magne, M. Galitzky, C. Thalamas, C. Brefel-Courbon, A. Pavy-LeTraon, P. Péran, O. Rascol (Toulouse, France)

    Objective: The aim of this study was to determine the structural correlates of depressive symptoms in MSA patients. Background: Depression is highly prevalent among patients…
  • 2018 International Congress

    Clinical practice of levodopa in parkinsonism

    AC. Chen (Taichung, Taiwan)

    Objective: This study is for the clinical effect of levodopa in parkinsonism. Background: Levodopa was common used in Parkinson disease. Levodopa induced dyskinesia(LID) is the…
  • 2018 International Congress

    Dual Competition between the Basal Ganglia and the Cortex: 1 from Action-Outcome to Stimulus-Response

    T. Boraud (Bordeaux, France)

    Objective: We propose a model of the interaction between the cortex, the basal ganglia and the thalamus based on a dual competition during instrumental conditioning.…
  • 2018 International Congress

    TreCap: Quantify and assess tremor in real-time with a new wearable device

    R. Bremm, J. Goncalves, K. Koch, F. Hertel (Belvaux, Luxembourg)

    Objective: To develop a wearable device with novel software features for real-time analysis and assessment of tremor in the clinical environment. Background: Visual examination of…
  • 2018 International Congress

    The effects of bright light therapy on depression, sleep and circadian rhythm in patients with Parkinson’s disease and a depressive disorder: Results of a double-blind randomized controlled trial

    S. Rutten, C. Vriend, J. Smit, H. Berendse, E. van Someren, A. Hoogendoorn, J. Twisk, Y. vd Werf, O. vd Heuvel (Amsterdam, Netherlands)

    Objective: The aim of this study was to assess the efficacy of Bright Light Therapy (BLT) in reducing depressive symptoms in patients with Parkinson’s disease…
  • « Previous Page
  • 1
  • …
  • 121
  • 122
  • 123
  • 124
  • 125
  • …
  • 177
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Welcome to the MDS Abstracts Site
  • Life expectancy with and without Parkinson’s disease in the general population
  • Nilotinib for treating MSA: A preclinical proof of concept study
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • An atypical and interesting feature of Parkinson´s disease
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley